Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
ORCID: Affiliation: 8 Neuroscience Theme, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney NSW 2006, Australia 9 Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 602 00 Brno, Czech Republic These authors contributed equally to this work
Its also approved for the prevention of cardiac events such as heart attack and stroke
You will receive an email confirmation and tracking number once your order is dispatched
Though we learned from these prior studies that increasing HDL does not reduce the risk for CV events, we also learned from REVEAL, which evaluated anacetrapib, that a mere 17% reduction in LDL was linked with a significant reduction in CV events
Disclosure The author reports no conflicts of interest in this work
US$ 28.40
US$ 29.41
US$ 21.52
